The Consortium (Clinical Endocannabinoid System Consortium, CESC) Revenue

Research Services • San Francisco, California, United States • 1-10 Employees

The Consortium (Clinical Endocannabinoid System Consortium, CESC) revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at The Consortium (Clinical Endocannabinoid System Consortium, CESC)

Alli Darrow

Executive Director

Company overview

Headquarters	San Francisco, California, United States
Website	theconsortium.io
NAICS	5417
Keywords	Life Sciences, Public Health, Precision Medicine, Medical Research, Healthcare Innovation, Clinical Practice, Endocannabinoid System
Founded	2015
Employees	1-10
Socials

About The Consortium (Clinical Endocannabinoid System Consortium, CESC)

In the last 50 years, scientists have been fascinated by a discovery made by Dr. Raphael Mechoulam: the Endocannabinoid System (ECS). This system has caught the attention of the medical world because of its significant impact on human health. The Clinical Endocannabinoid System Consortium (CESC) is dedicated to learning more about it and its role in influencing our well-being. The CESC consists of scientists, doctors, and other experts eager to understand how the ECS functions within our bodies, particularly its relationship with our everyday wellbeing. Our primary initiative, the Dosing Project, aims to determine the most effective doses of cannabis for medical conditions such as chronic pain and sleep disorders. By collecting data from numerous patients, we discover the best treatment options for different individuals. It's an exciting journey into uncharted territory, and we invite everyone to join us in exploring this promising frontier in healthcare. #LifeSciences #MedicalResearch #HealthcareInnovation #EndocannabinoidSystem #PrecisionMedicine #PublicHealth #ClinicalPractice

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

The Consortium (Clinical Endocannabinoid System Consortium, CESC) has never raised funding before.

The Consortium (Clinical Endocannabinoid System Consortium, CESC) Tech Stack

Discover the technologies and tools that power The Consortium (Clinical Endocannabinoid System Consortium, CESC)'s digital infrastructure, from frameworks to analytics platforms.

WP Fastest Cache

Performance

Cloudflare Bot Management

Security

Site Kit

Analytics

Swiper

JavaScript libraries

Elementor

Page builders

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Stripe

Payment processors

jQuery

JavaScript libraries

PHP

Programming languages

Bluehost

Hosting

Calendly

Appointment scheduling

Frequently asked questions

The Consortium (Clinical Endocannabinoid System Consortium, CESC) is located in San Francisco, California, US.

The Consortium (Clinical Endocannabinoid System Consortium, CESC) generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

The Consortium (Clinical Endocannabinoid System Consortium, CESC) has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

The Consortium (Clinical Endocannabinoid System Consortium, CESC) was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

The Consortium (Clinical Endocannabinoid System Consortium, CESC) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at The Consortium (Clinical Endocannabinoid System Consortium, CESC)

Alli Darrow

Executive Director

4.8

40,000 users